Search
Now showing items 1-1 of 1
Evaluating future biopharmaceutical inspection needs, infrastructure capability gaps, and technology development strategies
(Massachusetts Institute of Technology, 2012)
The biotechnology industry is undergoing a paradigm shift in the properties of the manufactured drug product. As therapeutic protein formulations change from agonist to antagonist methods of action, the concentration of ...